People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Technology, Biotech / Pharma, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alpha Source, Inc. | — | Other Technology | Series C | $102.7M | $154.7M | 2018 |
| TwinStrand Biosciences, Inc. | — | Biotech / Pharma | Series C | $85.0M | $132.2M | 2023 |
| MedCrypt Inc. | — | Medical Devices | Series B | $39.7M | $45.6M | 2025 |
Mike Pellini at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mike Pellini on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Pellini | 2 | 4 |
| Andrew Conrad | 2 | 2 |
| Chad Waite | 1 | 11 |
| Gary Kurtzman | 1 | 8 |
| Timothy Young | 1 | 7 |
| Steve Dow | 1 | 7 |
| Soma Somasegar | 1 | 5 |
| Tamir Meiri | 1 | 5 |
| ANDREW HARRISON | 1 | 4 |
| Jason Myers | 1 | 4 |
| Jesse Salk | 1 | 3 |
| Christopher Benoit | 1 | 3 |
| Chris Igielski | 1 | 2 |
| Michael Kranda | 1 | 2 |
| DAVID CANNER | 1 | 2 |
| Linden Rhoads | 1 | 2 |
| R. Brian McKernan | 1 | 2 |
| Ronnie Andrews | 1 | 2 |
| Brett Hemenway Falk | 1 | 1 |
| Eric Pancoast | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.